In line with that assumption is our finding that the drug combination of TIC10/ONC201 and ABT263 induces apoptosis in a BAX/BAK-dependent manner since knock-down of BAX/BAK significantly abrogated cell death by the combination therapy in T98G glioblastoma cells. Here, BAK1 is linked to glioblastoma.